Prognostic impact of the BRAF V600E mutation in patients with MSI-high metastatic colorectal cancer treated with immune checkpoint inhibitors
Claire Gallois, Margherita Ambrosini, Sara Lonardi, Emily Alouani, Rosine Guimbaud, Michael J. Overman, Frank A. Sinicrope, Thibault Mazard, Marie Decraecker, Javier Ros, Elena Élez, Simon Pernot, Chiara Cremolini, Alice Boilève, Pauline Parent, Priya Jayachandran, Marie Dutherage, Mathilde Mercier, Clémence Flecchia, Marwan Fakih, Francesco Sclafani, Filippo Pietrantonio, Julien Taı̈eb, David Tougeron
Topics & Concepts
MedicineColorectal cancerOncologyCancer researchImmune checkpointMutationV600ECancerInternal medicineMicrosatellite instabilityImmunotherapyBiologyGeneGeneticsAlleleMicrosatelliteGenetic factors in colorectal cancerCancer Immunotherapy and BiomarkersColorectal Cancer Treatments and Studies